Literature DB >> 16203885

Operative management of sacral chordoma.

Bruno Fuchs1, Ian D Dickey, Michael J Yaszemski, Carrie Y Inwards, Franklin H Sim.   

Abstract

BACKGROUND: Sacrococcygeal chordoma presents a difficult diagnostic and therapeutic problem, with a high rate of local recurrence. The purpose of this report is to define the importance of adequate surgical treatment for optimum outcome and survival.
METHODS: Fifty-two patients underwent surgical treatment for sacrococcygeal chordoma between 1980 and 2001. The series included eighteen female patients and thirty-four male patients, with an average age of fifty-six years (range, thirteen to seventy-six years) at the time of the diagnosis. The surgical approach depended on the level and extent of the lesion, with a posterior approach performed in twenty-two patients and a combined anteroposterior approach used in thirty. A wide surgical margin was achieved in twenty-one patients.
RESULTS: At an average of 7.8 years (range, 2.1 to twenty-three years) postoperatively, twenty-three patients were alive with no evidence of disease. Twenty-three patients (44%) had local recurrence. The rate of recurrence-free survival was 59% at five years and 46% at ten years. The overall survival rates were 74%, 52%, and 47% at five years, ten years, and fifteen years, respectively. The most important predictor of survival was a wide margin. All patients with a wide margin survived, and this survival rate was significantly different from that for patients who had had either marginal or intralesional excision (p = 0.0001). Of the twenty-one patients with a wide margin, seventeen (81%) had undergone a combined anteroposterior approach and only four had been treated with a posterior approach.
CONCLUSIONS: A wide surgical margin is the most important predictor of survival and of local recurrence in patients with sacrococcygeal chordoma. Use of a combined anteroposterior approach increases the likelihood of obtaining a wide margin. LEVEL OF EVIDENCE: Therapeutic Level IV.

Entities:  

Mesh:

Year:  2005        PMID: 16203885     DOI: 10.2106/JBJS.D.02693

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  104 in total

Review 1.  Imaging features of primary and secondary malignant tumours of the sacrum.

Authors:  E Thornton; K M Krajewski; K N O'Regan; A A Giardino; J P Jagannathan; N Ramaiya
Journal:  Br J Radiol       Date:  2011-12-13       Impact factor: 3.039

2.  CORR Insights(®): Sacral Insufficiency Fractures are Common after High-dose Radiation for Sacral Chordomas Treated With or Without Surgery.

Authors:  Joshua C Patt
Journal:  Clin Orthop Relat Res       Date:  2015-10-30       Impact factor: 4.176

3.  CORR(®) Tumor Board: Sacral Insufficiency Fractures are Common After High-dose Radiation for Sacral Chordomas Treated With or Without Surgery.

Authors:  Megan E Anderson; Jim S Wu; Sara O Vargas
Journal:  Clin Orthop Relat Res       Date:  2015-12-07       Impact factor: 4.176

4.  What Are the Functional Outcomes After Total Sacrectomy Without Spinopelvic Reconstruction?

Authors:  Piya Kiatisevi; Chaiwat Piyaskulkaew; Sombat Kunakornsawat; Bhasanan Sukunthanak
Journal:  Clin Orthop Relat Res       Date:  2017-03       Impact factor: 4.176

5.  Does preoperative transarterial embolization decrease blood loss during spine tumor surgery?

Authors:  Zhihong Qiao; Ningyang Jia; Qian He
Journal:  Interv Neuroradiol       Date:  2015-02       Impact factor: 1.610

Review 6.  Multidisciplinary management of primary tumors of the vertebral column.

Authors:  Wesley Hsu; Thomas A Kosztowski; Hasan A Zaidi; Michael Dorsi; Ziya L Gokaslan; Jean-Paul Wolinsky
Journal:  Curr Treat Options Oncol       Date:  2009-06-23

7.  Particle therapy using carbon ions or protons as a definitive therapy for patients with primary sacral chordoma.

Authors:  M Mima; Y Demizu; D Jin; N Hashimoto; M Takagi; K Terashima; O Fujii; Y Niwa; T Akagi; T Daimon; Y Hishikawa; M Abe; M Murakami; R Sasaki; N Fuwa
Journal:  Br J Radiol       Date:  2013-11-28       Impact factor: 3.039

8.  Spinal column chordoma: prognostic significance of clinical variables and T (brachyury) gene SNP rs2305089 for local recurrence and overall survival.

Authors:  Chetan Bettegowda; Stephen Yip; Sheng-Fu Larry Lo; Charles G Fisher; Stefano Boriani; Laurence D Rhines; Joanna Y Wang; Aron Lazary; Marco Gambarotti; Wei-Lien Wang; Alessandro Luzzati; Mark B Dekutoski; Mark H Bilsky; Dean Chou; Michael G Fehlings; Edward F McCarthy; Nasir A Quraishi; Jeremy J Reynolds; Daniel M Sciubba; Richard P Williams; Jean-Paul Wolinsky; Patricia L Zadnik; Ming Zhang; Niccole M Germscheid; Vasiliki Kalampoki; Peter Pal Varga; Ziya L Gokaslan
Journal:  Neuro Oncol       Date:  2017-03-01       Impact factor: 12.300

9.  "En bloc" resection of sacral chordomas by combined anterior and posterior surgical approach: a monocentric retrospective review about 29 cases.

Authors:  Arnaud Dubory; Gilles Missenard; Benoît Lambert; Charles Court
Journal:  Eur Spine J       Date:  2014-01-28       Impact factor: 3.134

10.  Recurrence and survival factors analysis of 171 cases of sacral chordoma in a single institute.

Authors:  Yongkun Yang; Xiaohui Niu; Yuan Li; Weifeng Liu; Hairong Xu
Journal:  Eur Spine J       Date:  2016-12-09       Impact factor: 3.134

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.